Hikma Pharmaceuticals is set this month to take its place alongside GlaxoSmithKline, AstraZeneca and Shire as a fourth blue-chip drug maker on the FTSE 100, Britain’s benchmark share index. Hikma will push Tullow Oil out of the esteemed club of…